Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Please provide your email address to receive an email when new articles are posted on . Seizure freedom was observed by 12 months and continued past 48 months of the open-label extension. Long-term ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they too may eventually see improvement, if not ...

Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

Please provide your email address to receive an email when new articles are posted on . Cannabidiol treatment was associated with median reduction of 67% to 99% in focal aware seizures. All ...

Researchers have proposed an open, bitfield-based numerical encoding that fits the entire ILAE 2025 seizure classification ...

Generalized epilepsy has traditionally been considered a seizure of the "'whole brain.'" However, new research has challenged this longstanding idea, since carefully targeting specific brain areas ...

Rapport Therapeutics Inc. ( RAPP ), a clinical-stage biotechnology company, has been steadily advancing its precision neuroscience pipeline, positioning itself as an increasingly notable contender in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...